| Date | Title | Description |
| 20.10.2025 | BioAgilytix Accelerates Global Growth with LC/MS Investments Across Three Continents | Expansions in the U.S., Europe, and Australia strengthen bioanalytical and CMC analytical services. DURHAM, NC, UNITED STATES, October 20, 2025 /EINPresswire.com/ -- BioAgilytix, the global leader in bioanalysis, has advanced its growth str... |
| 29.05.2025 | BioAgilytix Expands CMC Analytical Services; Appoints Jeff Patrick, PhD as Global CMC Lead to Drive Innovation and Scale | DURHAM, NC, UNITED STATES, May 29, 2025 /EINPresswire.com/ -- BioAgilytix, the leading global bioanalytical service provider, today announces the expansion of its global Chemistry, Manufacturing, and Controls (CMC) analytical testing capabi... |
| 27.05.2025 | Navigating IDE and IVDR Requirements in Drug Development, Upcoming Webinar Hosted by Xtalks | www.bioagilytix.com
In this free webinar, learn about navigating the US Investigational Device Exemption (IDE) and EU In Vitro Diagnostic Medical Devices Regulation (IVDR) for bioanalytical assays used for clinical trial inclusion/exclusion... |
| 30.05.2024 | BioAgilytix Welcomes Ed Amat as New Chief Growth Officer | Ed Amat, Chief Growth Officer DURHAM, NC, UNITED STATES, May 30, 2024 /EINPresswire.com/ -- BioAgilytix, a leading global bioanalytical laboratory, is pleased to announce the appointment of Ed Amat as Chief Growth Officer. Ed joins the BioA... |
| 30.11.2023 | Davide Molho, DVM, Life Sciences Industry Veteran joins BioAgilytix as CEO | Davide Molho, DVM DURHAM, NORTH CAROLINA, UNITED STATES, November 30, 2023 /EINPresswire.com/ -- BioAgilytix Labs, LLC (BioAgilytix), a leading global bioanalytical laboratory, today announced the appointment of Davide Molho, DVM, as its ne... |
| 08.05.2023 | BioAgilytix Expands Hamburg Lab to Support Customer Drug Development from Early Phase to Market Authorization | PCR platforms and Good Manufacturing Practices (GMP) certification further enhance European service offerings HAMBURG, GERMANY, May 8, 2023/EINPresswire.com/ -- BioAgilytix Labs, LLC (BioAgilytix), a leading global bioanalytical lab, today ... |
| 03.04.2023 | BioAgilytix Continues to Build Leadership in Europe | Robert J. Nelson, Ph.D.
Robert J. Nelson, Ph.D. Joins as Scientific Officer HAMBURG, GERMANY, April 3, 2023/EINPresswire.com/ -- BioAgilytix, a leading global bioanalytical laboratory, today announced the addition of Robert J. Nelson, Ph.D.... |
| 01.03.2023 | BioAgilytix Adds New VP of Business Development in Europe | HAMBURG, GERMANY, March 1, 2023 /EINPresswire.com/ -- BioAgilytix, a leading global bioanalytical laboratory, announced today the addition of Stephane de Fortescu as Vice President of Business Development in Europe. In this role, Stephane w... |
| 01.11.2022 | Potency Assays for ATMPs — Conception, Development, Validation, Matrixed Approaches and Assay Lifecycle, Upcoming Webinar Hosted by Xtalks | The control strategies are very different from more traditional biologics, with quantitation of potency posing one of the greatest challenges.
TORONTO (PRWEB) November 01, 2022
Advanced therapy medicinal products or ATMPs, are among the fas... |
| 17.11.2021 | The good times keep rolling for small, e-commerce business owners | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
If you’re a smaller, e-commerce shop owner looking to sell your business, now looks to be a prett... |
| 17.11.2021 | BioAgilytix Secures Significant New Investment from Global Investor Cinven to Fuel Continued Long-Term Growth | Investment Will Provide BioAgilytix with Additional Resources to Invest in Core Business and Drive Growth
DURHAM, N.C. and BRUSSELS, Belgium and LONDON, Nov. 17, 2021 /PRNewswire/ -- BioAgilytix, a leading global contract research organizat... |
| 17.11.2021 | The good times keep rolling for small, e-commerce business owners | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
If you’re a smaller, e-commerce shop owner looking to sell your business, now looks to be a prett... |
| 15.11.2021 | Total Antibody Assays for AAV-Based Gene Therapies – To Bridge or Not to Bridge, Upcoming Webinar Hosted by Xtalks | The goal of this webinar is to provide case studies for the two typically used assay formats for measuring total antibodies (direct and bridging) and discuss the challenges and rationales for using each of them in the AAV immunogenicity spa... |
| 14.10.2021 | BioAgilytix Closes Acquisition of Australia-based 360biolabs® | Following final government approval, 360biolabs, a BioAgilytix company, adds world-class virology & immunology expertise and LC/MS/MS small molecule capabilities to the company, enabling support of bioanalytical services across all geog... |
| 14.10.2021 | BioAgilytix : Closes Acquisition of Australia-based 360biolabs® | Following final government approval, 360biolabs, a BioAgilytix company, adds world-class virology & immunology expertise and LC/MS/MS small molecule capabilities to the company, enabling support of bioanalytical services across all geog... |
| 19.08.2021 | MicroConstants to Join BioAgilytix Family | Highly complementary transaction strengthens BioAgilytix's ability to support bioanalytical services across all major therapeutics in development; adds LC/MS/MS capabilities; and expands team of seasoned scientists
DURHAM, N.C., Aug. 19, 20... |
| 18.08.2021 | MicroConstants Signs Agreement to Join BioAgilytix Family, to be Known as BioAgilytix San Diego | |
| 18.08.2021 | MicroConstants to Join BioAgilytix Family
USA - English España - español | |
| 16.08.2021 | BioAgilytix to Purchase Australia-based 360biolabs® | Highly complementary transaction will strengthen company's ability to support bioanalytical services across all stages, development capabilities and geographies
DURHAM, N.C., Aug. 16, 2021 /PRNewswire/ -- BioAgilytix Labs, LLC (BioAgilytix)... |
| 25.03.2021 | Flow Cytometry Tools to Support Cellular Therapies, Upcoming Webinar Hosted by Xtalks | Multi-parameter flow cytometry is a powerful tool for both characterizing the cellular therapy and the patient’s immune response against the cell therapy.
TORONTO (PRWEB) March 25, 2021
Novel biotherapeutics such as cell therapy pose unique... |
| 16.12.2018 | Riverside Partners Exits BioAgilytix | BioAgilytix is a leading bioanalytical testing laboratory specializing in large molecule bioanalysis. With laboratory locations in North Carolina’s Research Triangle area and Hamburg, Germany, BioAgilytix provides PK, immunogenicity, biomar... |
| 12.12.2018 | Term Sheet — Wednesday, December 12 | A YEAR OF MEGA-DEALS
Good morning, Term Sheet readers.
Paid Content Securing the enterprise without boundaries From ExtraHop
“Through a fog of uncertainty, IPO markets around the world found a clear path forward and investment opportunities... |
| 11.12.2018 | Riverside Partners exits BioAgilytix | BioAgilytix is a leading bioanalytical testing laboratory specializing in large molecule bioanalysis. With laboratory locations in North Carolina’s Research Triangle area and Hamburg, Germany, BioAgilytix provides PK, immunogenicity, biomar... |
| 07.11.2018 | Riverside Partners Portfolio Company BioAgilytix to be Acquired by Cobepa S.A. | DURHAM, NC USA, BOSTON, MA USA & BRUSSELS, BELGIUM — |
| 15.03.2016 | Riverside Partners’ portfolio company, BioAgilytix, accelerates global expansion with the acquisition of German player, IPM Biotech | BOSTON, MA — BioAgilytix, a leading provider of contract bioanalytical testing services specializing in large molecule bioanalysis, has announced the acquisition of IPM Biotech, a German-based bioanalytical contract research laboratory reno... |
| 04.06.2013 | BioAgilytix Labs Secures Investment |
DURHAM, NC, Leading contract bioanalytical laboratory specializing in large molecule biologic drugs, secured an investment from Riverside Partners.
>> Click here for more funding data on BioAgilytix Labs
>> To export BioAgil... |
| 02.06.2013 | Riverside Partners Invests in BioAgilytix Labs | BOSTON, MA / DURHAM, NC — Riverside Partners, a Boston-based private equity firm, is pleased to announce that it has completed an investment in BioAgilytix Labs (“BioAgilytix”), a leading contract bioanalytical laboratory specializing in la... |
